FDA Premarket Approval: Process of Approving Lodine as a Drug

HRD-93-81 Published: Apr 12, 1993. Publicly Released: May 12, 1993.

Highlights

Pursuant to a congressional request, GAO reviewed the approval of the nonsteroidal, anti-inflammatory drug (NSAID) Lodine.

Sarah Kaczmarek

Managing Director

Office of Public Affairs

CarcinogensDrugsPatentsPharmaceutical industryPharmacological researchProduct evaluationProduct safetyDrug approvalsClinical trialsFood